共找到 58 份报告搜索:GLP-1药物

The Obesity Evolution: Refining our Global Anti-Obesity Medication (AOM) Market Model: Oral Options and OUS Poised to Capture Volumes

Goldman Sachs2026-06-0327

Global Healthcare: The Obesity Evolution: Framing global AOM peptide manufacturing capacity and implications for the branded/generic markets

Goldman Sachs2026-06-0545

阻塞性睡眠呼吸暂停(OSA)治疗药物临床试验设计指导原则

国家药品监督管理局药品审评中心2026-06-2918

China GLP-1: ADA updates reinforce a CNY85 Bn TAM

Bernstein2026-06-3024